Article Information
History
- October 20, 2020.
Article Versions
- Version 1 (May 6, 2020 - 07:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sara K. Nissen, PhD1,
- Sara A. Ferreira, MSc1,
- Marlene C. Nielsen, PhD2,
- Claudia Schulte, MSc3,
- Kalpana Shrivastava, PhD1,
- Dorle Hennig, PhD4,
- Anders Etzerodt, PhD1,
- Jonas H. Graversen, PhD4,
- Daniela Berg, MD3,5,
- Walter Maetzler, MD5,
- Anne Panhelainen, PhD6,
- Holger J. Møller, MD2,
- Kathrin Brockmann, MD3 and
- Marina Romero-Ramos, PhD1,#
- 1DANDRITE & Department of Biomedicine, Aarhus University, Aarhus, Denmark
- 2Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark
- 3Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research & German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany
- 4Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark
- 5Department of Neurology, Christian-Albrechts University, Kiel, Germany
- 6Institute of Biotechnology, University of Helsinki, Helsinki, Finland
- ↵#Corresponding author:
Marina Romero-Ramos, Dept. of Biomedicine, Aarhus University, Høegh-Guldbergsgade 10, DK-8000 Aarhus C, Denmark. Phone: +45 87167854. E-mail: mrr{at}biomed.au.dk
Posted October 20, 2020.
“Soluble CD163 changes indicate monocyte association with cognitive deficits in Parkinson’s disease”
